Editorial: Nanomedicines for the Treatment of Tuberculosis: Role of Nanocarriers and Functional Excipients

Recent Pat Antiinfect Drug Discov. 2017;12(2):84. doi: 10.2174/1574891X1202180503101725.

Authors

Abdus Samad¹, Iram Nazish², Sarwar Beg³

Affiliations

¹ Department of Pharmacokinetics & Statistics Fortis Clinical Research Ltd. Faridabad, Haryana, India.
² Department of Pharmacognosy HK College of Pharmacy Oshiwara Mumbai, India.
³ Product Development Research Jubilant Generics Limited Noida, U.P., India.

PMID: 29745316
DOI: 10.2174/1574891X1202180503101725

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antitubercular Agents / administration & dosage*
Antitubercular Agents / therapeutic use
Drug Carriers / therapeutic use*
Humans
Nanomedicine*
Tuberculosis, Pulmonary / drug therapy*

Substances

Antitubercular Agents
Drug Carriers